These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10447748)

  • 1. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.
    Song R; Porgador A; Harding CV
    Immunology; 1999 Jun; 97(2):316-24. PubMed ID: 10447748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway.
    Song R; Harding CV
    J Immunol; 1996 Jun; 156(11):4182-90. PubMed ID: 8666786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH.
    Chefalo PJ; Grandea AG; Van Kaer L; Harding CV
    J Immunol; 2003 Jun; 170(12):5825-33. PubMed ID: 12794107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
    Harding CV; Song R
    J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH.
    Chefalo PJ; Harding CV
    J Immunol; 2001 Aug; 167(3):1274-82. PubMed ID: 11466343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
    Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
    Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
    Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors.
    Bansal P; Mukherjee P; Basu SK; George A; Bal V; Rath S
    J Immunol; 1999 Apr; 162(8):4430-7. PubMed ID: 10201979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
    Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
    Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
    Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
    Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.
    Regnault A; Lankar D; Lacabanne V; Rodriguez A; Théry C; Rescigno M; Saito T; Verbeek S; Bonnerot C; Ricciardi-Castagnoli P; Amigorena S
    J Exp Med; 1999 Jan; 189(2):371-80. PubMed ID: 9892619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
    Svensson M; Wick MJ
    Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
    Chen L; Jondal M
    Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.
    Brossart P; Bevan MJ
    Blood; 1997 Aug; 90(4):1594-9. PubMed ID: 9269778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.